We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Safety of and Immune Response to an HIV Vaccine (VRC-HIVDNA009-00-VP) Administered With Interleukin-2/Immunoglobulin (IL-2/Ig) DNA Adjuvant in Uninfected Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00069030
Recruitment Status : Completed
First Posted : September 16, 2003
Last Update Posted : November 8, 2012
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)